0

Infectious Complications in Biologic and Targeted Therapies

Erschienen am 19.11.2022, Auflage: 1/2022
149,79 €
(inkl. MwSt.)

Lieferbar innerhalb 1 - 2 Wochen

In den Warenkorb
Bibliografische Daten
ISBN/EAN: 9783031113628
Sprache: Englisch
Umfang: x, 473 S., 7 s/w Illustr., 19 farbige Illustr., 40
Einband: gebundenes Buch

Beschreibung

This book aims to approach the epidemiology, diagnosis and management of infectious complications related to the use of biologic and targeted therapies. The first part is a general overview on the epidemiology and prevention of infections with the use of these agents. Timelines, pre-treatment evaluation, use of vaccines and travel counseling. In the second part, we will analyze the specific risk of infections associated with the use of the most important agents. The third part approach the problem on a syndromic point of view. For example, how to evaluate pulmonary infiltrates in a patient receiving biologic agents. This part III includes the most difficult and conflicting syndromes that clinicians may face when evaluating these patients. This book is intended not only for infectious diseases specialists, but also for different medical specialties prescribing biologic and targeted therapies.

Autorenportrait

Carlos Cervera, MD, PhDDivision of Infectious Diseases, Department of Medicine. University of Alberta.1-124F Clinical Sciences Building. 11350 83 Ave. Edmonton T6G 2G3Alberta, CanadaPrimary email address: cerveraa@ualberta.ca Jose Maria Aguado, MD, PhD Unit of Infectious Diseases, Research Institute Hospital "12 de Octubre" (i + 12), University Hospital "12 de Octubre", Complutense University of Madrid Madrid, Spain Primary email address: jaguadog1@gmail.com

Weitere Artikel vom Autor "Carlos Cervera/Jose Maria Aguado"

Alle Artikel anzeigen